Early cognitive decline and its assessment in idiopathic Parkinson disease and its correlation with duration of illness
DOI:
https://doi.org/10.18203/2349-3933.ijam20221094Keywords:
Parkinson disease, Cognitive decline, SCOPA COGAbstract
Background: Parkinson disease (PD) is one of the most common age-related brain disorders, with cardinal symptoms rigidity, bradykinesia, resting tremor and postural instability. These are dopamine-related motor symptoms. PD is increasingly recognized as heterogeneous multisystem disorder involving other neurotransmitter associated with nonmotor symptoms. In which cognitive decline is the most common and important NMS. cognitive decline in PD makes profound effect on patient quality of life and imposes significant burden on the caregiver.
Methods: Hospital based cross sectional study conducted among 52 patients of idiopathic Parkinson disease, 61 to 80 years of age (fulfilling UKPDS brain bank criteria) at GSVM medical college, Kanpur during February 2020 to October 2021 using SCOPA COG scale.
Results: Using SCOPA COG score in 52 patients, 17 (33%) patients found with declined cognition There was weak negative correlation between total score and duration of illness (p=0.091), weak negative correlation between executive function (assessed by dice) and duration of illness (p=0.047) and a moderate negative correlation between visuospatial function (assessed by assembling pattern) and duration of illness (p=0.003).
Conclusions: Significant cognitive decline found with increase in duration of illness in terms of visuospatial function.
References
Santangelo G, Vitale C, Picillo M, et al. Mild cognitive impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism Relat Disord. 2015;21(10):1219-26.
Hely A, Morris JG, Reid WG, Traffificante R. Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20(2):190-9.
Williams-Gray CH, Mason SL, Evans JR. The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiat. 2013;84(11):1258-64.
Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain. 2007; 130(7):1787-98.
Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int J Geriat Psychiatry. 1999;14:866-74.
Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geritatr Soc. 2000;48(8):938-42.
Levy G, Tang MX, Louis ED. The association of incident dementia with mortality in PD. Neurol. 2002; 59:1708-13.
Sanyal J, Banerjee TK, Rao VR. Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study. Am J Alzheimers Dis Other Demen. 2014;29(7):630-6.
Fang C, Lv L, Mao S, Dong H, Liu B. Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment. Parkinsons Dis. 2020;2020:2076942.
Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017; 13(4):217-31.
Kehagia AA, Barker RA, Robbins TW. Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener Dis. 2013;11(2):79-92.
Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60(3):387-92.
Das D, Biswas A, Roy A, Sauerbier A, Bhattacharyya KB. Cognitive impairment in idiopathic Parkinson's disease. Neurol India. 2016;64(3):419-27.
